S N Snow1, G T Reizner. 1. Department of Surgery, University of Wisconsin-Madison 53705.
Abstract
BACKGROUND: Mucinous eccrine carcinoma (MEC) is a rare malignant tumor that typically arises in the periorbital area. METHODS: The authors report the 73rd case of primary MEC of the skin. This patient's clinicopathologic findings and the world literature are reviewed. RESULTS: Patient ages range from 8-84 years (median, 63 years). The male-to-female ratio was approximately 2:1. The racial distribution was 67% white, 32% black, and 4% Asian. Primary MEC originates in the head and neck region in approximately 75% of patients. The most common location was the periorbital area (40% or 29 of 73 patients). The local recurrence rate after conventional surgery was: eyelid, 34%; scalp, 36%; and face, 33%. CONCLUSIONS: Primary MEC is often a slow-growing tumor that may recur after traditional surgical excision. Recurrent eyelid MEC tends to be locally destructive with a regional metastatic rate of 3.5% (1 of 29). The regional metastatic rate for all sites was 11%, and the distant metastatic rate was 3%.
BACKGROUND:Mucinous eccrine carcinoma (MEC) is a rare malignant tumor that typically arises in the periorbital area. METHODS: The authors report the 73rd case of primary MEC of the skin. This patient's clinicopathologic findings and the world literature are reviewed. RESULTS:Patient ages range from 8-84 years (median, 63 years). The male-to-female ratio was approximately 2:1. The racial distribution was 67% white, 32% black, and 4% Asian. Primary MEC originates in the head and neck region in approximately 75% of patients. The most common location was the periorbital area (40% or 29 of 73 patients). The local recurrence rate after conventional surgery was: eyelid, 34%; scalp, 36%; and face, 33%. CONCLUSIONS: Primary MEC is often a slow-growing tumor that may recur after traditional surgical excision. Recurrent eyelid MEC tends to be locally destructive with a regional metastatic rate of 3.5% (1 of 29). The regional metastatic rate for all sites was 11%, and the distant metastatic rate was 3%.
Authors: Bhuvaneswari Ramaswamy; Tanios Bekaii-Saab; Larry J Schaaf; Gregory B Lesinski; David M Lucas; Donn C Young; Amy S Ruppert; John C Byrd; Kristy Culler; Diedre Wilkins; John J Wright; Michael R Grever; Charles L Shapiro Journal: Cancer Chemother Pharmacol Date: 2009-09-23 Impact factor: 3.333
Authors: Christopher K H Burris; Meisha L Raven; Maria E Rodriguez; Heather D Potter; Mark J Lucarelli; Daniel M Albert Journal: Ophthalmic Plast Reconstr Surg Date: 2017 May/Jun Impact factor: 1.746
Authors: Meghana Agni; Meisha L Raven; Randy C Bowen; Nora V Laver; Patricia Chevez-Barrios; Tatyana Milman; Charles G Eberhart; Steven Couch; Daniel D Bennett; Daniel M Albert; R Nick Hogan; Paul O Phelps; Hillary Stiefel; Norberto Mancera; Martin Hyrcza; Ami Wang; Christopher K H Burris; Eric A Steele; Ashley A Campbell; Heather D Potter; Mark J Lucarelli Journal: Am J Surg Pathol Date: 2020-08 Impact factor: 6.298